AWM Investment Company Inc. decreased its position in shares of electroCore, Inc. (NASDAQ:ECOR – Free Report) by 68.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 163,133 shares of the company’s stock after selling 346,961 shares during the quarter. AWM Investment Company Inc. owned approximately 2.45% of electroCore worth $2,644,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in shares of electroCore by 31,250.0% in the 4th quarter. JPMorgan Chase & Co. now owns 3,762 shares of the company’s stock valued at $61,000 after purchasing an additional 3,750 shares during the period. DnB Asset Management AS acquired a new stake in shares of electroCore in the fourth quarter valued at approximately $180,000. NewEdge Advisors LLC purchased a new position in shares of electroCore during the fourth quarter worth approximately $274,000. Jane Street Group LLC acquired a new position in shares of electroCore in the 4th quarter valued at $278,000. Finally, Marshall Wace LLP acquired a new position in shares of electroCore in the 4th quarter valued at $438,000. Hedge funds and other institutional investors own 26.74% of the company’s stock.
electroCore Trading Up 0.2%
Shares of ECOR stock opened at $5.31 on Wednesday. The company has a market capitalization of $39.41 million, a P/E ratio of -2.90 and a beta of 0.92. The business’s 50 day moving average is $6.41 and its two-hundred day moving average is $11.85. electroCore, Inc. has a twelve month low of $4.47 and a twelve month high of $19.49.
Insider Activity
In other news, Director Thomas J. Errico acquired 6,000 shares of electroCore stock in a transaction that occurred on Monday, March 17th. The stock was purchased at an average price of $8.10 per share, for a total transaction of $48,600.00. Following the completion of the transaction, the director now directly owns 256,401 shares in the company, valued at approximately $2,076,848.10. This trade represents a 2.40% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders have bought a total of 17,000 shares of company stock valued at $104,890 over the last quarter. Corporate insiders own 19.70% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts have issued reports on ECOR shares. LADENBURG THALM/SH SH lowered their price objective on shares of electroCore from $28.00 to $26.00 and set a “buy” rating on the stock in a research report on Thursday, March 13th. HC Wainwright reiterated a “buy” rating and set a $25.00 target price on shares of electroCore in a research note on Thursday, March 13th.
Get Our Latest Research Report on ECOR
electroCore Company Profile
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Featured Articles
- Five stocks we like better than electroCore
- What is a Dividend King?
- Best Utilities Stocks for Stability and Growth in 2025
- Expert Stock Trading Psychology Tips
- Qualcomm’s Re-Entry Into the CPU Market May Not Be Enough
- How to Use the MarketBeat Dividend Calculator
- Applied Digital’s Strategic AI Play Gains Momentum
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.